GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Ending Cash Position

Alzinova AB (OSTO:ALZ) Ending Cash Position : kr22.03 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Ending Cash Position?

Alzinova AB's Ending Cash Position for the quarter that ended in Dec. 2023 was kr22.03 Mil.

Alzinova AB's quarterly Ending Cash Position declined from Jun. 2023 (kr36.58 Mil) to Sep. 2023 (kr32.91 Mil) and declined from Sep. 2023 (kr32.91 Mil) to Dec. 2023 (kr22.03 Mil).

Alzinova AB's annual Ending Cash Position increased from Dec. 2021 (kr28.84 Mil) to Dec. 2022 (kr32.04 Mil) but then declined from Dec. 2022 (kr32.04 Mil) to Dec. 2023 (kr22.03 Mil).

Alzinova AB Ending Cash Position Historical Data

The historical data trend for Alzinova AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB Ending Cash Position Chart

Alzinova AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 33.73 55.98 28.84 32.04 22.03

Alzinova AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.04 22.69 36.58 32.91 22.03

Alzinova AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Alzinova AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=32.038+-10.012
=22.03

Alzinova AB's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=32.905+-10.879
=22.03

Alzinova AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Alzinova AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Alzinova AB (OSTO:ALZ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Ending Cash Position
Comparable Companies
OSTO:ELIC OSTO:BIOVIC B OSTO:NXTCL OSTO:ISOFOL XSAT:CESSA OSTO:ACE OSTO:SPRINT OSTO:LIPUM OSTO:SIMRIS B OSTO:ZICC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
78D:Germany
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Website
https://www.alzinova.com
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is also engaged in development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody. The product is in clinical development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB (OSTO:ALZ) Headlines

No Headlines